Business
Cipla Ltd Press Release Dec 10 2023
Cipla Limited has informed the Exchange regarding a press release dated December 10, 2023, titled "Voluntary Nationwide Recall of one lot of Vigabatrin for Oral Solution, USP 500mg due to leaking sachets by InvaGen Pharmaceuticals Inc., wholly owned subsidiary of the Company in USA".
About this update from Cipla Ltd
Cipla Limited has informed the Exchange regarding a press release dated December 10, 2023, titled "Voluntary Nationwide Recall of one lot of Vigabatrin for Oral Solution, USP 500mg due to leaking sachets by InvaGen Pharmaceuticals Inc., wholly owned subsidiary of the Company in USA". View Attachment
More from Cipla Ltd
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda in the US
September 4, 2026
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in...
September 3, 2026